Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report Q1 2022: Revenue growth of 111%

Company Announcement no. 8/202210 May 2022   The Board of Directors for Wirtek A/S has today approved the interim report for first quarter of 2021 for the Wirtek Group. The detailed interim report for Q1 2021 is attached to this announcement. CEO Michael Aaen comments: “Our strong momentum from 2021 continued in Q1 2022 with solid order intake, positive adjustment of our expectations to 2022 and the release of our updated growth strategy, Accelerate25XL. Revenue grew by 111% the first quarter of 2022 compared to Q1 last year and EBITDA was up 76%, although Wirtek has been

Wyld Networks to base USA operations in Missouri

Wyld Networks to partner with World Trade Center St. Louis and STL Partnership to base Wyld’s USA operations in Missouri to develop satellite IoT for US agriculture and supply chain sectors.Nearly half of the USA’s total agricultural productivity is harvested within a 500-mile radius of St. Louis. Additionally, many of the sector’s major businesses are headquartered in Missouri. Furthermore, St Louis is integral to the US logistics infrastructure having key major highway intersections, rail and air hubs and the confluence of the Mississippi and Missouri rivers. The Missouri Department of

Notice of annual general meeting in Polymer Factory Sweden AB

Shareholders in Polymer Factory Sweden AB, reg. nr 556695-9531 (the “Company”), are hereby summoned to the Annual General Meeting on Wednesday 8 June 2022 through advance voting. Attendance at the meeting is only possible via postal ballot.The Annual General meeting will be executed only through postal voting, in accordance with section 22 of the Act (2022:121) on temporary exceptions to facilitate the execution of general meetings in companies and other associations. This means that shareholders will not be allowed to participate in person or by proxy at the general meeting held on 8 June

NILAR INTERNATIONAL AB INTERIM REPORT Q1 2021

NILAR EXECUTES ON REVISED STRATEGYJanuary – March 2022 in summary · Net sales, MSEK -4.2 (5.4). · Production MWh 0.0 (3.2). · Delivered batteries 52 (992). · Gross profit[1)] MSEK -40.8 (-69.6). · EBITDA MSEK -48,1 (-78.0). · Operating profit (EBIT) MSEK -63.5 (-96.0). · Profit for the period MSEK -74.2 (-114.4). · Earnings per share before/after dilution SEK -1.63 (-22,53). Significant events during the first quarter · Cost savings during the quarter have exceeded management expectations. · The negotiations following the two redundancy notices issued in

Unique Alfa Laval technology recovers industrial waste heat for reuse in Hamburg’s district heating network

Alfa Laval’s specially designed heat exchangers will recover waste heat from a sulphuric acid plant for reuse in district heating in Hamburg, Germany. The initial waste heat recovery process was installed in 2018, and the plant is now expanding the project to provide heating for more approximately 23,000 households, offices, hotels and the university. The project is part of a German government initiative to increase the city’s green footprint.Aurubis Group is a leading global provider of non-ferrous metals and one of the largest copper recyclers worldwide. The related sulphuric acid process

TF Bank: Monthly statistics April 2022

The total loan portfolio amounted to SEK 11,655 million at the end of April. Compared to April 2021, the loan portfolio has increased by 29 % in local currencies.  Month Apr-22 Apr-21 ChangeConsumer Lending   New lending, SEK million 431 350 23 %Ecommerce Solutions   Transaction volume*, SEK million 739 585 26 %Credit Cards   New lending, SEK million 312 147 112 %  Cumulative for the year Jan-Apr 22 Jan-Apr 21 ChangeConsumer Lending   New lending, SEK million 1

Calliditas Therapeutics to participate in upcoming investor conferences

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that its management team will participate in the following upcoming investor conferences and events: · The 8[th] Annual LSX World Congress on May 10-11, 2022 in London, United Kingdom · The ABGSC Life Science Summit on May 18–19, 2022, in Stockholm, Sweden. · H.C. Wainwright Hybrid Global Investment Conference on May 23-26, 2022. · Jefferies Healthcare Conference on June 8-10, 2022 in New York City, USA. · Citi European Healthcare Conference on June 14–16, 2022 in London, United

Cary Group commits to the Science Based Targets initiative

Cary Group aims to be an industry leader when it comes to climate action. The company has, as a part of its strategy, set a high and clear objective on how to reduce its climate impact. Therefore, Cary Group commits to the Science Based Targets initiative (SBTi) as a next step to reach its reduction targets in line with the 1,5°C goal of the Paris Agreement by 2030.Cary Group has committed to set targets in line with the Science Based Targets initiative (SBTi), consistent with the Paris Agreement. This is a natural step in Cary Group’s sustainable strategy, which incorporates sustainability

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for April 2022

Hamilton, Bermuda, May 10, 2022   Commercial update: In April 2022, the Company achieved average time charter equivalent earnings of approximately US$23,600 per day, gross. The Company’s six vessels trading on index-linked time charter earned approximately US$20,300 per day, gross, including average daily scrubber benefits of approximately US$1,600 per day. The Company’s two vessels trading on fixed time charter earned approximately US$33,700 per day, gross, including average daily scrubber benefits of approximately US$2,300 per day.   The Baltic 5TC Capesize Index averaged

Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma

· Targovax has entered into an agreement with Oslo University Hospital (OUS) to test TG01 in a phase 1/2 trial in 20 patients with RAS mutant multiple myeloma · The trial will be sponsored by OUS and led by Dr. Fredrik Schjesvold, an international leader in the field and founder of the Oslo Myeloma Center, the largest Myeloma center in the Nordics · The trial will be the first time TG vaccination is tested in patients together with the new adjuvant QS-21 STIMULON™ from collaboration partner AgenusOslo, Norway, 10 May 2022 – Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology

Interim report January – March 2022

First quarter in brief · Net sales amounted to 9.9 million SEK (14.7), which represents a decrease in sales of 33 percent. · Operating profit amounted to -3.6 million SEK (2.5). · Net profit for the period amounted to -3.5 million SEK (2.7). · Earnings per share amounted to -0.08 SEK (0.07).   Significant events during the first quarter During the period, a directed share issue was carried out for an amount equivalent to 60 million SEK before transaction costs. SyntheticMR US Inc has entered a partnership with Hyland Healthcare. A sales and support

Veg of Lund updates strategy and revises objectives with focus on growth

The Board of Directors of Veg of Lund AB has conducted a strategic review of the business and decided on an updated strategy and revised targets in order to increase sales. The company clarifies that the business model consists of a hybrid between own and licensed production and sales. The strategy is to accelerate sales by appointing licensees in more countries. The goal is to reach a turnover of MSEK 420 with a positive operating result by the year 2025.Veg of Lund’s current board took office after an extraordinary general meeting on 31 January 2022 and has conducted a review of the

COSEL announces 6W high isolation DC/DC converters for medical, industrial and ICT applications

•    High input/output isolation 3kVAC, 4.2kVDC•    Medical isolation 2MOOP - 250VAC working voltage•    Low input/output capacitance – 20 pF maximum•    Ultra-wide input voltage (4:1) - 4.5V to 18V ; 9V to 36V ; 18V to 76V•    Ruggedized pins connector•    Made in Japan - 5 years warranty COSEL Co, Ltd (6905: Tokyo) today announced the addition of a new series of high isolation 6W DC/DC converters for medical, industrial and ICT applications. Packaged in a Single In Line (SIP) type 8, the COSEL MH6 series has a reinforce isolation of 3kVAC, 4.2kVDC, complies with medical

Nordstjernan issues call options in Momentum Group

CEO Ulf Lilius and CFO Niklas Enmark of Momentum Group AB (publ) (“Momentum Group”) have acquired call options for shares in Momentum Group. The call options were issued on market-based terms by Momentum Group’s principal owner, Nordstjernan AB. The call options do not entail any dilution for the other shareholders. Momentum Group is not participating in the issue of the call options and will not be charged with any related costs.     Peter Hofvenstam President and CEO Nordstjernan AB     Questions will be answered by:   Peter Hofvenstam, CEO, Nordstjernan E-

Polymer Factory Sweden AB (publ) Interim Report Q1 2022

The period in summary First quarter, January-March 2022 · The Company received a strategically important order in January 2022 from a global life science company · A new Product Manager joined Polymer Factory on February 1, 2022 · An incentive program for key personnel was implemented Key Figures (KSEK) Jan-Mar Jan-Mar 2022 2021Net sales    451 783Profit (loss) for the period    -1,052 -677Total assets 10,506 15,410Equity / assets ratio (%) 91

Moberg Pharma´s Interim report January - March 2022

EUROPEAN MARKETING AUTHORIZATION APPLICATION SUBMITTED AND NORTH AMERICAN PHASE 3 STUDY STARTEDFIRST QUARTER JAN-MAR 2022 · EBITDA SEK -4.8 million (-5.4) * · Operating profit (EBIT) SEK -5.4 million (-6.1) * · Profit after tax SEK -4.4 million (-5.0) * · Total profit SEK -4,4 million (18.6) · Diluted earnings per share SEK -0.10 (0.46) * · Cash and cash equivalents amounted to SEK 73.4 million (133.6) * All comparative figures refer to continuing operations SIGNIFICANT EVENTS IN THE FIRST QUARTER · Moberg Pharma submitted a marketing authorization application

Navamedic ASA: Q1 2022 financial results

Oslo, 10 May 2022 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, grew revenues with 7.4 percent in the first quarter of 2022 compared to the same period in 2021.   “We had a solid first quarter with continued growth driven by new product launches and strong development for existing products within medical nutrition, consumer health and branded generics. Our type of business will always experience some volatility in revenue growth from quarter to quarter due to pipeline effects, and in the first

Nordic Mining ASA (EN Expand:NOM) - Interim report per 31 March 2022

Please find enclosed Nordic Mining’s interim report and company presentation for the first quarter of 2022. The interim report and company updates will be presented digitally today, Tuesday 10 May 2022 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast will be available on: https://channel.royalcast.com/landingpage/hegnarmedia/20220510_9/ Summary of important events in the first quarter of 2022 and year to date: KEY EVENTS ·

Karnov Group reports first quarter results 2022

Strong growth and good cash flowFINANCIAL HIGHLIGHTS First QUARTER · Net sales increased by 9.2% to SEK 255 m (234), organic growth was 4.8% and acquired growth accounted for 2.1%. Currency effect was 2.3%. · EBITA amounted to SEK 85 m (95) with EBITA margin of 33.5% (40.7%). Items affecting comparability amounted to SEK 19 m (0). · Adjusted EBITA amounted to SEK 104 m (95) with adjusted EBITA margin of 40.8% (40.7%). · Net result amounted to SEK 24 m (40), impacted by items affecting comparability of SEK 19 m (0). · Earnings per share amounted to SEK 0.23 (0.41). Earnings

Lantmännen and Spendrups in renewed partnership on sustainable cultivation methods for barley

During the spring, Lantmännen and Spendrups have initiated a new collaboration where malt barley, the main ingredient in beer, for the first time is grown according to Climate & Nature - Lantmännen's cultivation program for Farming of the Future. This means that cultivation methods that reduce climate impact and benefit biodiversity will be used. The crop is already in the soil and the malt barley is to be harvested in the fall, and then used in beer brewed in early 2023.Spendrups has been using malt barley from Lantmännen for many years. The collaboration around Lantmännen's cultivation

Read original

Etteplan supports research towards an additive manufacturing breakthrough in the Swedish ProThin project

Etteplan Oyj, press release, 10 May 2022 9 am EEST Etteplan’s additive manufacturing expertise is playing a crucial role in an ongoing additive manufacturing (AM) project of the Swedish strategic innovation program Produktion2030. The ProThin project aims at discovering how to produce components with thin walls and narrow channels with the AM technology Laser Powder Bed Fusion (LPBF). Etteplan is in the forefront of the ProThin project, part of the Swedish strategic innovation program Produktion2030. The goal is to enable production of thin walls and narrow channels with Laser Powder

Gaming Innovation Group reports Q1 2022

Gaming Innovation Group Inc. (GiG) reports Q1 2022 revenues* of €19.1 million and an EBITDA of €6.5 million.  “I am satisfied with the Company’s progress in the first quarter, and we now move toward an exciting second quarter where our global strategic position across multiple areas of high value within the iGaming industry creates truly exciting prospects for growth across the business units”, says Richard Brown, CEO of GiG.  Financial Highlights · GiG achieved all time high revenues* in Q1 2022 of €19.1m (15.0), an increase of 27% YoY, all organic growth  · EBITDA was €6.5m (

There are no items matching the current filter
There are no more items matching the current filter
Back to top